Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kawaguchi, R; Nunomura, S; Umehara, N; Nikaido, T; Huppertz, B; Tanaka, T; Ra, C.
Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice.
Placenta. 2012; 33(7):540-547
Doi: 10.1016/j.placenta.2012.03.010
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Huppertz Berthold
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Objectives: The antiphospholipid syndrome (APS) is characterized by the presence of circulating anti-phospholipid antibodies (aPLs), is a leading cause for thromboembolic events, repeated miscarriage, fetal loss and is a major risk factor for fetal growth restriction (FGR) and preeclampsia. In human, anti-beta 2 glycoprotein I (a beta 2GPI) antibody is one of the aPLs and considered to be a specific and important marker for APS. However, pathophysiological changes induced by a beta 2GPI antibodies in FGR are largely unknown. Methods: In the present study, we developed a murine FGR model induced by multiple injections of WBCAL-1, a well-characterized mouse a beta 2GPI monoclonal antibody. Results: Administration of WBCAL-1, but not the isotype control antibody and saline, into pregnant mice specifically decreased the size of fetuses and placentas without affecting the number of delivered pups. Also, a significant increase in urinary albumin and electron microscopic changes, such as splitting layers of basal membranes in the placental labyrinth and rearrangement of pores in glomerular endothelial cells, were observed in WBCAL-1 treated mice. WBCAL-1 injection did not induce any changes in blood pressure and typical parameters of blood thromboembolic symptoms. Furthermore, FcR gamma deficiency protected the fetuses from a beta 2GPI antibody-induced injuries. Conclusions: Our present findings suggest that proteinuria is a symptom associated with APS-related FGR with placental and renal tissue injuries, and that FcR gamma might be a molecular target for prevention of a beta 2GPI antibody-mediated obstetrical pathologies. (C) 2012 Elsevier Ltd. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Antibodies, Antiphospholipid - immunology
- Antibodies, Monoclonal - administration & dosage
- Antiphospholipid Syndrome - immunology
- Disease Models, Animal -
- Female -
- Fetal Growth Retardation - immunology
- Mice -
- Mice, Inbred BALB C -
- Mice, Knockout -
- Mice, Nude -
- Microscopy, Electron -
- Placenta - immunology
- Pregnancy -
- Proteinuria -
- Receptors, IgG - deficiency
- beta 2-Glycoprotein I - immunology
- Find related publications in this database (Keywords)
- Antiphospholipid antibody syndrome (APS)
- Fetal growth restriction (FGR)
- Mouse model
- Anti-beta 2 glycoprotein I (beta 2GPI) antibody
- FcR gamma deficient mice